Literature DB >> 15687265

Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Tracy E Strecker1, Thomas J Spady, Beverly S Schaffer, Karen A Gould, Amy E Kaufman, Fangchen Shen, Mac T McLaughlin, Karen L Pennington, Jane L Meza, James D Shull.   

Abstract

Estrogens stimulate proliferation and enhance survival of the prolactin (PRL)-producing lactotroph of the anterior pituitary gland and induce development of PRL-producing pituitary tumors in certain inbred rat strains but not others. The goal of this study was to elucidate the genetic bases of estrogen-induced pituitary tumorigenesis in reciprocal intercrosses between the genetically related ACI and Copenhagen (COP) rat strains. Following 12 weeks of treatment with the synthetic estrogen diethylstilbestrol (DES), pituitary mass, an accurate surrogate marker of absolute lactotroph number, was increased 10.6-fold in ACI rats and 4.5-fold in COP rats. Composite interval mapping analyses of the phenotypically defined F(2) progeny from the reciprocal crosses identified six quantitative trait loci (QTL) that determine the pituitary growth response to DES. These loci reside on chromosome 6 [Estrogen-induced pituitary tumor (Ept)1], chromosome 3 (Ept2 and Ept6), chromosome 10 (Ept9), and chromosome 1 (Ept10 and Ept13). Together, these six Ept loci and one additional suggestive locus on chromosome 4 account for an estimated 40% of the phenotypic variance exhibited by the combined F(2) population, while 34% of the phenotypic variance was estimated to result from environmental factors. These data indicate that DES-induced pituitary mass behaves as a quantitative trait and provide information that will facilitate identification of genes that determine the tumorigenic response of the pituitary gland to estrogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687265      PMCID: PMC1449615          DOI: 10.1534/genetics.104.039370

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  42 in total

1.  Map Manager QTX, cross-platform software for genetic mapping.

Authors:  K F Manly; R H Cudmore; J M Meer
Journal:  Mamm Genome       Date:  2001-12       Impact factor: 2.957

2.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

3.  Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat.

Authors:  Djuana M E Harvell; Tracy E Strecker; Benjamin Xie; Karen L Pennington; Rodney D McComb; James D Shull
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

4.  Strain-limited Development of Tumors of the Pituitary Gland in Mice Receiving Estrogens.

Authors:  W U Gardner; L C Strong
Journal:  Yale J Biol Med       Date:  1940-05

5.  Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.

Authors:  D M Harvell; T E Strecker; M Tochacek; B Xie; K L Pennington; R D McComb; S K Roy; J D Shull
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis.

Authors:  C Teuscher; R J Butterfield; R Z Ma; J F Zachary; R W Doerge; E P Blankenhorn
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Genetic separation of tumor growth and hemorrhagic phenotypes in an estrogen-induced tumor.

Authors:  D L Wendell; A Herman; J Gorski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study.

Authors:  K Kovacs; L Stefaneanu; S Ezzat; H S Smyth
Journal:  Arch Pathol Lab Med       Date:  1994-05       Impact factor: 5.534

9.  Women with prolactinoma--effect of pregnancy and lactation on serum prolactin and on tumour growth.

Authors:  U Holmgren; G Bergstrand; K Hagenfeldt; S Werner
Journal:  Acta Endocrinol (Copenh)       Date:  1986-04

10.  The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.

Authors:  Jyotsna Pandey; Anas Bannout; Douglas L Wendell
Journal:  Carcinogenesis       Date:  2004-05-27       Impact factor: 4.944

View more
  16 in total

1.  Genetic mapping of loci controlling diethylstilbestrol-induced thymic atrophy in the Brown Norway rat.

Authors:  Karen A Gould; Tracy E Strecker; Kimberly K Hansen; Kimberly K Bynoté; Kelli A Peterson; James D Shull
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

2.  CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Authors:  Yunguang Tong; Jin Zhou; Jun Mizutani; Hidenori Fukuoka; Song-Guang Ren; Arthur Gutierrez-Hartmann; H Phillip Koeffler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2011-10-06

3.  Ept7 influences estrogen action in the pituitary gland and body weight of rats.

Authors:  Scott G Kurz; Kirsten L Dennison; Nyssa Becker Samanas; Maureen Peters Hickman; Quincy A Eckert; Tiffany L Walker; Andrea S Cupp; James D Shull
Journal:  Mamm Genome       Date:  2014-01-22       Impact factor: 2.957

4.  Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5.

Authors:  Karen A Gould; Jyotsna Pandey; Cynthia M Lachel; Clare R Murrin; Lisa A Flood; Karen L Pennington; Beverly S Schaffer; Martin Tochacek; Rodney D McComb; Jane L Meza; Douglas L Wendell; James D Shull
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

5.  Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.

Authors:  James D Shull; Cynthia M Lachel; Clare R Murrin; Karen L Pennington; Beverly S Schaffer; Tracy E Strecker; Karen A Gould
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

6.  Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.

Authors:  Beverly S Schaffer; Kristin M Leland-Wavrin; Scott G Kurz; John A Colletti; Nicole L Seiler; Christopher L Warren; James D Shull
Journal:  Cancer Prev Res (Phila)       Date:  2012-11-14

Review 7.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

8.  Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat.

Authors:  Scott G Kurz; Kimberly K Hansen; Mac T McLaughlin; Vijay Shivaswamy; Beverly S Schaffer; Karen A Gould; Rodney D McComb; Jane L Meza; James D Shull
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

9.  Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

Authors:  Rachel L Ruhlen; Dana M Willbrand; Cynthia L Besch-Williford; Lixin Ma; James D Shull; Edward R Sauter
Journal:  Breast Cancer Res Treat       Date:  2008-09-09       Impact factor: 4.872

Review 10.  Genetic variation in sensitivity to estrogens and breast cancer risk.

Authors:  D Joseph Jerry; James D Shull; Darryl L Hadsell; Monique Rijnkels; Karen A Dunphy; Sallie S Schneider; Laura N Vandenberg; Prabin Dhangada Majhi; Celia Byrne; Amy Trentham-Dietz
Journal:  Mamm Genome       Date:  2018-02-27       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.